Quince Therapeutics, Inc. (QNCX) M&A Call Prepared Remarks Transcript
Quince Therapeutics, Inc. held an M&A call on May 18, 2026, to discuss its acquisition of OrphAI Therapeutics. The call featured remarks from CEO Dirk Thye and was facilitated by LifeSci Advisors. Participants were informed about the company's financial performance and future outlook during the session.
- ▪Quince Therapeutics, Inc. is acquiring OrphAI Therapeutics.
- ▪The M&A call took place on May 18, 2026, at 10:00 AM EDT.
- ▪Dirk Thye, CEO of Quince Therapeutics, led the call.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4906209-quince-therapeutics-inc-qncx-m-and-a-call-prepared-remarks-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
